Andre Mu
University of Melbourne
31 Papers
15 Citations
Andre Mu is an academic researcher from University of Melbourne. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 8, co-authored 23 publications. Previous affiliations of Andre Mu include Salk Institute for Biological Studies & University of Miami.
Chat about Author
Papers
Engineering the microbiome for animal health and conservation
Se Jin Song,Douglas C. Woodhams,Douglas C. Woodhams,Cameron Martino,Celeste Allaband,Andre Mu,Sandrine Javorschi-Miller-Montgomery,Jan S. Suchodolski,Rob Knight +8 more
TL;DR: The rapid progress currently being made in human medicine and the examples to date of application of probiotics and other microbiome-directed therapies in taxa ranging from horses to salamanders to bees suggest excellent prospects for these technologies as they are further developed.
92
Staphylococcus aureus small colony variants impair host immunity by activating host cell glycolysis and inducing necroptosis.
Tania Wong Fok Lung,Ian R. Monk,Karen P. Acker,Andre Mu,Nancy Wang,Sebastián A. Riquelme,Silvia Pires,Loreani P. Noguera,Felix Dach,Stanislaw J. Gabryszewski,Benjamin P Howden,Alice Prince +11 more
TL;DR: Glycolysis and the generation of mitochondrial reactive oxygen species were sufficient to induce necroptosis, a caspase-independent mechanism of host cell death that failed to eradicate S. aureus and instead promoted ΔhemB SCV pathogenicity.
Klebsiella pneumoniae induces host metabolic stress that promotes tolerance to pulmonary infection.
Tania Wong Fok Lung,Daniel Charytonowicz,Kristin G. Beaumont,Shivang S. Shah,Shwetha Hara Sridhar,Claire L. Gorrie,Andre Mu,Casey E. Hofstaedter,D.C. Varisco,Thomas H. McConville,Marija Drikic,Brandon Fowler,Andreacarola Urso,Weifeng Shi,Dario Fucich,Medini K. Annavajhala,Ibrahim Khan,Irina Oussenko,Nancy Francoeur,Melissa Smith,Brent R. Stockwell,Ian A. Lewis,Abderrahman Hachani,Swikrity Upadhyay Baskota,Anne-Catrin Uhlemann,Danielle Ahn,R. Ernst,Benjamin P Howden,Robert Sebra,Alice Prince +29 more
TL;DR: In this paper , the authors combined in situ metabolic imaging and transcriptional analyses to demonstrate that Kp ST258 activates host glutaminolysis and fatty acid oxidation, which creates an oxidant-rich microenvironment conducive to the accumulation of anti-inflammatory myeloid cells.
59
Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection.
Andre Mu,Daniel McDonald,Alan K. Jarmusch,Cameron Martino,Cameron Martino,Caitriona Brennan,MacKenzie Bryant,Gregory Humphrey,Julia Toronczak,Tara Schwartz,Dominic S. Nguyen,Gail Ackermann,Anthony D'Onofrio,Steffanie A. Strathdee,Robert T. Schooley,Pieter C. Dorrestein,Rob Knight,Saima Aslam +17 more
TL;DR: In this paper, a single patient with Staphylococcus aureus device infection showed a largely unchanged microbiota profile during 4 weeks of phage therapy when added to systemic antibiotics.
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria
Andre Mu,William P. Klare,Sarah L. Baines,Chi Nam Ignatius Pang,Romain Guérillot,Nichaela Harbison-Price,Nadia Keller,Jonathan J. Wilksch,Nguyen Thi Khanh Nhu,Minh-Duy Phan,Bernhard Keller,Brunda Nijagal,Dedreia Tull,Saravanan Dayalan,Hwa H. Chua,Dominik Skoneczny,Jason Koval,Abderrahman Hachani,Anup Shah,Nitika Neha,Snehal R. Jadhav,Sally R. Partridge,Amanda J. Cork,Kate M. Peters,Olivia M. Bertolla,Stephan Brouwer,Steven J. Hancock,Laura Álvarez-Fraga,David M. P. De Oliveira,Brian M. Forde,Ashleigh L. Dale,Warasinee Mujchariyakul,C. J. Walsh,Ian R. Monk,Anna Fitzgerald,Mabel Lum,Carolina Correa-Ospina,Piklu Roy Chowdhury,Robert G. Parton,James J. De Voss,J. Beckett,Francois Monty,Jessica McKinnon,Xiaomin Song,John R. Stephen,Marie Everest,Matthew I. Bellgard,Matthew Tinning,Michael Leeming,Dianna M Hocking,Leila Jebeli,Nancy Wang,Nouri L. Ben Zakour,Serhat A. Yasar,Stefano Vecchiarelli,Tonia Russell,Thiri Zaw,Tyrone Chen,Don Teng,Zena Kassir,Trevor Lithgow,Adam Jenney,Jason N. Cole,Victor Nizet,Tania C. Sorrell,Anton Y. Peleg,David L. Paterson,Scott A. Beatson,Jemma X. Wu,Mark P. Molloy,Anna E. Syme,Robert J. A. Goode,Adam Hunter,Grahame Bowland,Nicholas P. West,Marc R. Wilkins,Steven P. Djordjevic,Mark R. Davies,Torsten Seemann,Benjamin P Howden,Dana Pascovici,Sonika Tyagi,Ralf B. Schittenhelm,David P De Souza,Malcolm J. McConville,Jonathan R. Iredell,Stuart J. Cordwell,Richard A. Strugnell,Timothy P. Stinear,Mark A. Schembri,Mark Walker +90 more
TL;DR: In this article , the authors developed a reference dataset enabling the identification of common bacterial targets for therapeutic intervention, applied a standardized genomic, transcriptomic, proteomic and metabolomic technological framework to multiple clinical isolates of four sepsis-causing pathogens: Escherichia coli, Klebsiella pneumoniae species complex, Staphylococcus aureus and Streptococcus pyogenes.